secwatch.observer — SEC 8-K summary
======================================

Issuer:     Relay Therapeutics, Inc. (RLAY)
CIK:        0001812364
Form:       8-K
Filed at:   2024-09-11T23:59:59+00:00
Accession:  0001193125-24-217296
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Relay Therapeutics prices $200M public offering of common stock at $7.00/share
------------------------------------------------------------------------------

- Public offering of 28.57M shares at $7.00/share; gross proceeds ~$200M.
- Net proceeds estimated at ~$189.5M after underwriting discounts and expenses.
- Underwriters granted 30-day option to purchase up to an additional 4.29M shares.
- Offering expected to close on September 12, 2024; lead managers include Goldman Sachs, TD Cowen, Stifel, BofA Securities.
- All shares sold by the company; proceeds will support clinical-stage precision medicine programs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812364/000119312524217296/0001193125-24-217296-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812364/000119312524217296/d892276d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-217296

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer